Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Weak
Earnings
Strong
Growth
Earnings
Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Description
Bluechiip Ltd. engages in the development of information technology-based temperature and identification tracking solution for biosamples in the health and life sciences industry. Its products include Sample Storage, Readers, and Softwar. The company was founded by Brett G. Schwarz and Ronald B. Zmood on May 20, 2003 and is headquartered in Scoresby, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.03
Trade Value (12mth)
AU$2,639.00
1 week
0%
1 month
20%
YTD
-51.31%
1 year
-69.86%
All time high
0.28
EPS 3 yr Growth
-1.300%
EBITDA Margin
-650.40%
Operating Cashflow
-$4m
Free Cash Flow Return
-125.10%
ROIC
-149.90%
Interest Coverage
-195.30
Quick Ratio
0.70
Shares on Issue (Fully Dilluted)
839m
HALO Sector
Industrials
Next Company Report Date
29-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
10 July 24 |
BCT expansion order from Global Pharma client and Update
×
BCT expansion order from Global Pharma client and Update |
05 July 24 |
Change of Company Secretary
×
Change of Company Secretary |
19 June 24 |
Change in substantial holding
×
Change in substantial holding |
17 June 24 |
Application for quotation of securities - BCT
×
Application for quotation of securities - BCT |
17 June 24 |
Cleansing Notice
×
Cleansing Notice |
12 June 24 |
Bluechiip completes placement
×
Bluechiip completes placement |
12 June 24 |
Proposed issue of securities - BCT
×
Proposed issue of securities - BCT |
12 June 24 |
Proposed issue of securities - BCT
×
Proposed issue of securities - BCT |
12 June 24 |
Company Update
×
Company Update |
07 June 24 |
Trading halt
×
Trading halt |
05 June 24 |
Bluechiip launches next generation workstation
×
Bluechiip launches next generation workstation |
14 May 24 |
BCT Partners with Biopharma Group to Distribute in the UK
×
BCT Partners with Biopharma Group to Distribute in the UK |
30 April 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
30 April 24 |
Open Briefing
×
Open Briefing |
16 April 24 |
Notification regarding unquoted securities - BCT
×
Notification regarding unquoted securities - BCT |
16 April 24 |
Notification of cessation of securities - BCT
×
Notification of cessation of securities - BCT |
16 April 24 |
Change of Director's Interest Notice - AM
×
Change of Director's Interest Notice - AM |
18 March 24 |
Change of Director's Interest Notice - MOH
×
Change of Director's Interest Notice - MOH |
18 March 24 |
Change of Director's Interest Notice - IK
×
Change of Director's Interest Notice - IK |
18 March 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
18 March 24 |
Change of Director's Interest Notice - AM
×
Change of Director's Interest Notice - AM |
18 March 24 |
Change of Director's Interest Notice - AC
×
Change of Director's Interest Notice - AC |
14 March 24 |
Application for quotation of securities - BCT
×
Application for quotation of securities - BCT |
13 March 24 |
Response to ASX Query Letter
×
Response to ASX Query Letter |
12 March 24 |
Results of Entitlement Offer
×
Results of Entitlement Offer |
04 March 24 |
Investor Presentation
×
Investor Presentation |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.